Daily non-political popular news in brief.

Mutation of the COX2 gene can double or treble a woman's risk of ovarian cancer

Researchers in Portugal have discovered that a specific mutation of the COX2 gene seems to play a role in the onset of ovarian cancer, increasing women's susceptibility to developing the disease. Dr. Ana Carina Pereira told the European Cancer Conference that the discovery raises the possibility that it might be possible to use nonsteroidal anti-inflammatory drugs, such as aspirin and ibuprofen, which are used already for other conditions, to prevent ovarian cancer developing in women with the COX2 mutation.

Read more »

Keywords: mutation, cox2, gene, double, treble, woman, risk, ovarian, cancer

« Previous | Next »

Similar news on "Mutation of the COX2 gene can double or treble a woman's risk of ovarian cancer":

1. Other highlights from the March 21 JNCI
   03-20-2007 · EurekAlert!
   Also in the March 21 JNCI are a study on the link between fat intake and breast cancer risk, a plant compound that may decrease breast cancer risk, a critique of the use of progression-free survival in cancer clinical trials, and a mutation to a mismatch repair gene that is associated with colorectal cancer.
   Similar news · Read more »
   
2. Varying prevalence among ethnic groups of gene mutation that increases risk of breast cancer
   12-25-2007 · EurekAlert!
   Among several US racial/ethnic groups examined, Hispanic women were found to have the highest prevalence of the cancer-associated gene mutation BRCA1 at 3.5 percent, with Asian Americans having the lowest prevalence (0.5 percent), according to a study in the Dec. 26 issue of JAMA.
   Similar news · Read more »
   
3. Family structure size could affect breast cancer risk prediction accuracy for BRCA gene testing
   06-19-2007 · EurekAlert!
   Researchers have found that the probability of the breast cancer gene mutation BRCA among women with a history of breast cancer is greater when the number of older, female relatives in the family is smaller, according to a study in the June 20 issue of JAMA. This finding may challenge the accuracy of some breast cancer prediction models, which may not take family structure into account.
   Similar news · Read more »
   
4. Researchers find new gene linked to breast cancer
   10-07-2007 · EurekAlert!
   Researchers in a multicenter international study have identified a new gene that, if mutated, may increase a woman's risk of breast cancer by more than a third.
   Similar news · Read more »
   
5. Should children be permitted to get genetic testing for BRCA 1/2 mutations?
   01-15-2008 · EurekAlert!
   It's an ethical dilemma with serious implications. Should children be tested for gene mutations that predispose them to developing breast cancer and/or ovarian cancer later in life? New research suggests the next generation of parents may support testing minors even when any steps to reduce that risk will be postponed until adulthood -- a finding that challenges current policies.
   Similar news · Read more »
   
6. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer
   03-21-2007 · EurekAlert!
   Scientists have found a gene mutation that can dramatically reduce the number of colon polyps that develop, potentially cutting the risk of cancer. Researchers studying mice prone to develop polyps discovered that animals carrying the damaged gene had about 90 percent fewer polyps in the small intestine and colon. Because people with large numbers of polyps are at higher risk for colon cancer, the finding may provide new ways to diagnose, prevent and treat it.
   Similar news · Read more »
   
7. Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
   01-01-2008 · EurekAlert!
   Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations. After up to nine years of follow-up, BRCA1/2 mutation carriers were 28 percent less likely to die from the disease, even though women with the BRCA mutations are significantly more likely to develop ovarian and breast cancers.
   Similar news · Read more »
   
8. New clues to breast cancer development in high-risk women
   09-11-2007 · EurekAlert!
   Physicians who treat women with the breast cancer susceptibility gene BRCA1 often remove their patients' ovaries to eliminate the source of estrogen they believe fuels cancer growth. Yet they also know that anti-estrogen therapies don't work to treat breast or ovarian cancer that might develop. That paradox has led scientists to question exactly how, or if, estrogen is involved in cancer development and whether removal of ovaries makes sense.
   Similar news · Read more »
   
9. New pathway provides more clues about BRCA1 role in breast cancer
   01-15-2008 · EurekAlert!
   A breast cancer gene's newly discovered role in repairing damaged DNA may help explain why women who inherit a mutated copy of the gene are at increased risk for developing both breast and ovarian cancer.
   Similar news · Read more »
   
10. Men unaware of their cancer risk when female relatives test positive for BRCA mutation
    12-14-2007 · EurekAlert!
    Men whose mothers, sisters or daughters test positive for a cancer-causing gene mutation also have an increased risk of developing the disease but are unaware of that risk. That is the conclusion of a study at Fox Chase Cancer Center exploring how families communicate genetic test results.
    Similar news · Read more »